Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

Weezuhl- If the HAP results are good, partners will be lined up, if no partner, then we know.

There is no reason to believe the chewing studies are going to be good, but even if they are, I disagree with your statement. An important point to consider: of the ten drugs FDA-approved with an ADF label, five have never hit the market: Troxyca, Ventrela, Morphabond, Roxybond, and Targiniq. There is a problem in the ADF opioid market, especially for extended-release opioids not called OxyContin. If companies who have FDA approval and ADF label are not even bothering to manufacture their drugs, then who the hell is going to partner for the same kind of drug, especially with such a sketchy history?